SS Innovations International Q4 2025 Earnings Report

SS Innovations International EPS Results

• Actual EPS: $0.04
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

SS Innovations International Revenue Results

• Actual Revenue: $14.53 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

SS Innovations International Announcement Details

• Quarter: Q4 2025
• Date: 1/13/2026
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

SS Innovations International (NASDAQ:SSII) is a medical technology company focused on developing, manufacturing and commercializing robotic-assisted surgical systems. Through its operating business in India, the company offers the SSi Mantra robotic surgery platform, which is designed to support minimally invasive procedures across multiple surgical specialties.

The company’s product portfolio includes the SSi Mantra system, robotic instruments and related accessories, as well as surgical training, installation, maintenance and support services. Its technology is intended to provide surgeons with enhanced visualization, precision and control during procedures while supporting hospitals seeking to expand their minimally invasive surgery capabilities.

SS Innovations serves hospitals and healthcare providers in India and is pursuing opportunities in international markets. The company was founded by Dr. Sudhir Srivastava, who serves as its chairman and chief executive officer. Its operations and product development are centered on expanding access to robotic surgery through systems designed for hospitals in emerging and established healthcare markets.